Cargando…
Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer
Identifying oncogenes that promote cancer cell proliferation or survival is critical for treatment of colorectal cancer. The Brother of Regulator of Imprinted Sites (BORIS) is frequently expressed in most types of cancer, but rarely in normal tissues. Aberrantly expressed BORIS relates to colorectal...
Autores principales: | Zhang, Yanmei, Fang, Mengdie, Song, Yongfei, Ren, Juan, Fang, Jianfei, Wang, Xiaoju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241680/ https://www.ncbi.nlm.nih.gov/pubmed/28098226 http://dx.doi.org/10.1038/srep40786 |
Ejemplares similares
-
Brother of regulator of imprinted sites inhibits cisplatin-induced DNA damage in non-small cell lung cancer
por: Zhang, Yanmei, et al.
Publicado: (2020) -
Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression
por: Akhtar, Mohammad Salman, et al.
Publicado: (2023) -
Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy
por: Asano, Takuya, et al.
Publicado: (2016) -
Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy
por: Horibe, Ryota, et al.
Publicado: (2017) -
BORIS-mediated generation of circular RNAs induces inflammation
por: Xu, Hao, et al.
Publicado: (2022)